Scholars Central

Conference abstractPublished 11 Jul 2016

Cytokines in atherosclerosis: Molecular mechanisms underlying their actions and promising therapeutic targets

Authors: Dipak P Ramji, Thomas S Davies, Hayley Gallagher, Joe W E Moss, Faizah B Jaffar, Wijdan Al-Ahmadi

Cardiff University, UK

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Atherosclerosis and its complications are responsible for more deaths worldwide than any other disease. Atherosclerosis is an inflammatory disorder of medium and large arteries that involves both the innate and adaptive immune systems. The inflammatory response in atherosclerosis is orchestrated by cytokines that are produced by all the cells involved in this disease. Cytokines are generally classified as pro- or anti-atherogenic. Approaches to inhibit the actions of pro-atherogenic cytokines include neutralization via blocking antibodies or soluble decoy receptors and the use of inhibitors of intracellular signaling pathways. On the other hand, approaches for anti-atherogenic cytokines include their local delivery and the use of agents that augment their expression/actions. More than fifty cytokines have been found to be involved in atherosclerosis. It is therefore important that a thorough understanding is obtained of their actions in this disease in order to identify new therapeutic targets or approaches and validate their therapeutic potential. Research in my laboratory has focused on cytokine signaling in atherosclerosis with emphasis on macrophages, which play key roles in all stages of this disease and represent promising therapeutic targets. New insights have been obtained on the molecular mechanisms underlying the actions of interferon-gamma, transforming growth factor-beta, interleukin-33 and tumor necrosis factor-like protein 1A on key macrophage processes in atherosclerosis (e.g. foam cell formation, regulation of gene expression, amplification of the inflammatory response). These will be presented in the context of current therapies and future developments in this field.

Subjects

Cardiology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical and Experimental Cardiology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical and Experimental Cardiology
  • SubjectCardiology
  • BylineArticles whose byline prints “Dipak P Ramji”
  • BylineArticles whose byline prints “Thomas S Davies”
  • BylineArticles whose byline prints “Hayley Gallagher”
  • BylineArticles whose byline prints “Joe W E Moss”
  • BylineArticles whose byline prints “Faizah B Jaffar”
  • BylineArticles whose byline prints “Wijdan Al-Ahmadi”